These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 650752)

  • 1. The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading.
    Gilbert HA; Logan JL; Kagan AR; Friedman HA; Cove JK; Fox M; Muldoon TM; Lonni YW; Rowe JH; Cooper JF; Nussbaum H; Chan P; Rao A; Starr A
    J Urol; 1978 Apr; 119(4):488-92. PubMed ID: 650752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The natural history of patients less than 40 years old with bladder tumors.
    Kurz KR; Pitts WR; Vaughan ED
    J Urol; 1987 Mar; 137(3):395-7. PubMed ID: 3820365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?
    Jakse G; Loidl W; Seeber G; Hofstädter F
    J Urol; 1987 Jan; 137(1):39-43. PubMed ID: 3795364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transitional cell neoplasms of the urinary bladder. Can biologic potential be predicted from histologic grading?
    Jordan AM; Weingarten J; Murphy WM
    Cancer; 1987 Dec; 60(11):2766-74. PubMed ID: 3677010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of transitional cell tumours of the bladder. Prognosis and causes of death.
    Sjolin KE; Nyholm K; Trautner K
    Acta Pathol Microbiol Scand A; 1976 Sep; 84(5):361-74. PubMed ID: 970124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystectomy after radiotherapeutic ablation of invasive transitional cell cancer.
    Deweerd JH; Colby MY; Myers RP; Cupps RE
    J Urol; 1977 Aug; 118(2):260-1. PubMed ID: 894803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial bladder cancer: progression and recurrence.
    Heney NM; Ahmed S; Flanagan MJ; Frable W; Corder MP; Hafermann MD; Hawkins IR
    J Urol; 1983 Dec; 130(6):1083-6. PubMed ID: 6644886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative management of muscle-infiltrating bladder cancer: prospective experience.
    Herr HW
    J Urol; 1987 Nov; 138(5):1162-3. PubMed ID: 3669160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
    Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW
    Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expectant management of small, recurrent, noninvasive papillary bladder tumors.
    Soloway MS; Bruck DS; Kim SS
    J Urol; 2003 Aug; 170(2 Pt 1):438-41. PubMed ID: 12853794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nested variant of bladder transitional cell carcinoma: Review of 12 cases and review of the literature.
    Carrion-Ballardo CJ; Gala-Solana L; Portillo-Martin JA; Azueta-Etxebarria A; Truan-Cacho D; Campos-Juanatey F
    Actas Urol Esp; 2015; 39(6):387-91. PubMed ID: 25670479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of low grade papillary bladder tumors.
    Herr HW; Donat SM; Reuter VE
    J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the urinary bladder. Histologic staging and grading in relation to survival in a surgically treated material.
    Schroeder E; Christensen TB; Jacobsen F; Sjolin KE
    Acta Chir Scand Suppl; 1973; 433():126-31. PubMed ID: 4513502
    [No Abstract]   [Full Text] [Related]  

  • 17. Surveillance of stage O, grade I bladder cancer by cytology alone--is it acceptable?
    Morrison DA; Murphy WM; Ford KS; Soloway MS
    J Urol; 1984 Oct; 132(4):672-4. PubMed ID: 6471210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. II. Prognostic importance.
    Carbin BE; Ekman P; Gustafson H; Christensen NJ; Silfverswärd C; Sandstedt B
    J Urol; 1991 May; 145(5):972-5; discussion 975-6. PubMed ID: 2016812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
    Sözen S; Akbal C; Sökmensüer C; Ekici S; Ozen H
    Urol Int; 2002; 69(3):200-6. PubMed ID: 12372888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent platinum and docetaxel chemotherapy and external radical radiotherapy in patients with invasive transitional cell bladder carcinoma. A preliminary report of tolerance and local control.
    Varveris H; Delakas D; Anezinis P; Haldeopoulos D; Mazonakis M; Damilakis J; Metaxaris G; Chondros N; Mavromanolakis E; Daskalopoulos G; Dimitrakopoulos A; Kranidis A
    Anticancer Res; 1997; 17(6D):4771-80. PubMed ID: 9494605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.